10x Genomics is trading 4.4% up at $58.58, with no clear company-specific catalyst identified.

  • No clear company-specific announcement or reliable news report dated August 17, 2026 explains the move.
  • Recent coverage highlights the August 6 earnings release, including raised 2026 revenue guidance and strong Atera orders, but that catalyst predates the current session.
  • The broader market is slightly weaker, so the gain does not appear driven by broad index momentum; trading activity and volume details were unavailable.